Skip to content

Arrowhead Research ARWR Short-Term Investments

Short-Term Investments at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.12B-9.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$60.3M
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$585.74M-11.2%
Royalty Pharma logo
Royalty PharmaRPRX
$21.9M+81.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.05B+40.1%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's short-term investments?
Arrowhead Research (ARWR) reported short-term investments of $1.6B in Q1 2026.
How has Arrowhead Research's short-term investments changed year-over-year?
Arrowhead Research's short-term investments increased by 75.0% year-over-year, from $911.7M to $1.6B.
What is the long-term trend for Arrowhead Research's short-term investments?
Over 5 years (2020 to 2025), Arrowhead Research's short-term investments has grown at a 51.5% compound annual growth rate (CAGR), from $86.89M to $692.82M.
What does short-term investments mean?
Investments that the company expects to convert into cash within one year.
How do you interpret short-term investments?
An increase indicates effective treasury management of excess capital, whereas a decrease may signal the use of these funds for operational expenses.
How does short-term investments compare across companies?
Common among well-capitalized biotech firms that hold proceeds from equity offerings in conservative, interest-bearing instruments.